Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: Involvement of PARP-1 and p53 proteins

Toxicology Letters

Volumn 178, Issue 2, 2008, Pages 71-76

  Santoro, Antonietta ^a   Bianco, Giuseppe ^a   Picerno, Patrizia ^a   Aquino, Rita Patrizia ^a   Autore, Giuseppina ^a   Marzocco, Stefania ^a   Gazzerro, Patrizia ^a   Lioi, Maria Brigida ^b   Bifulco, Maurizio ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF BASILICATA   (Italy)

Author keywords

Chromosome aberrations; p53; PARP 1; Sister chromatid exchanges; Verbascoside; Verminoside

Indexed keywords

ACTEOSIDE; IRIDOID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN P53; VERMINOSIDE;

ADULT; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; GENOTOXICITY; HUMAN; LYMPHOCYTE; MASS SPECTROMETER; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SISTER CHROMATID EXCHANGE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CHROMOSOME ABERRATIONS; CHROMOSOMES; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; HUMANS; IRIDOIDS; LYMPHOCYTES; MALE; MITOTIC INDEX; MUTAGENS; PHENOLS; POLY(ADP-RIBOSE) POLYMERASES; SISTER CHROMATID EXCHANGE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TUMOR SUPPRESSOR PROTEIN P53;

BACTERIA (MICROORGANISMS);

EID: 42649087401     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.02.006     Document Type: Article

References (33)

1. Agapova L.S., Ilyinskaya G.V., Turovets N.A., Ivanov A.V., Chumakov P.M., and Kopnin B.P. Chromosome changes caused by alterations of p53 expression. Mutat. Res. 354 (1996) 129-138
2. Akunyili D.N., Houghton P.J., and Roman A. Antimicrobial activities of the stembark of Kigelia pinnata. J. Ethnopharmacol. 35 (1991) 173-177
3. Houghton P.J., Photiou A., Uddin S., Shah P., Browning M., Jackson S.J., and Retsas S. Activity of extracts of Kigelia pinnata against melanoma and renal carcinoma cell lines. Planta Med. 60 (1994) 430-433
4. Innocente S.A., Abrahamson J.L.A., Cogswell J.P., and Lee J.M. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. 96 (1999) 2147-2152
5. Jackson S.J., Houghton P.J., Retsas S., and Photiou A. In vitro cytotoxicity of norviburtinal and isopinnatal from Kigelia pinnata against cancer cell lines. Planta Med. 66 (2000) 758-761
6. Johnson R.D., and Jasin M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19 (2000) 3398-3407
7. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., and Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51 (1991) 6304-6311
8. Koo K.A., Sung S.H., Park J.H., Kim S.H., Lee K.Y., and Kim Y.C. In vitro neuroprotective activities of phenylethanoid glycosides from Callicarpa dichotoma. Planta Med. 71 (2005) 778-780
9. Kunvari M., Paska C., Laszlo M., Orfi L., Kovesdi I., Eros D., Bokonyi G., Keri G., and Gyurjan I. Biological activity and structure of antitumor compounds from Plantago media L. Acta Pharm. Hung. 69 (1999) 232-239
10. Lane D.P. p53, guardian of the genome. Nature 358 (1992) 15-16
11. Lee J.H., Lee J.Y., Kang H.S., Jeong C.H., Moon H., Whang W.K., Kim C.J., and Sim S.S. The effect of acteoside on histamine release and arachidonic acid release in RBL-2H3 mast cells. Arch. Pharm. Res. 29 (2006) 508-513
12. Lee J.Y., Woo E.R., and Kang K.W. Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J. Ethnopharmacol. 97 (2005) 561-566
13. Lee K.W., Kim H., Lee Y., Park H.J., Choi J.W., Ha J., and Lee K.T. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Carcinogenesis 28 (2007) 1928-1936
14. Lee K.Y., Jeong E.J., Lee H.S., and Kim Y.C. Acteoside of Callicarpa dicotoma attenuates scopolamine-induced memory impairments. Biol. Pharm. Bull. 29 (2006) 71-74
15. Lioi M.B., Scarfì M.R., Santoro A., Barbieri R., Zeni O., Salvemini F., Di Berardino D., and Ursini M.V. Cytogenetic damage and induction of pro-oxidant state in human lymphocytes exposed in vitro to gliphosate, vinclozolin, atrazine and DPX-E9636. Environ. Mol. Mutagen. 32 (1998) 39-46
16. Moideen S.V.K., Houghton P.J., Rock P., Croft S.L., and Aboagye-Nyame F. Activity of extracts and naphthoquinones from Kigelia pinnata against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Planta Med. 65 (1999) 536-540
17. Morgan W.F., Fero M.L., Land M.C., and Winegar R.A. Inducible expression and cytogenetic effects of the EcoRI restriction endonuclease in Chinese hamster ovary cells. Mol. Cell. Biol. 8 (1988) 4204-4211
18. Nelson W.G., and Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 11 (1994) 12-19
19. Ohno T., Inoue M., Ogihara Y., and Saracoglu I. Antimetastatic activity of acteoside, a phenylethanoid glycoside. Biol. Pharm. Bull. 25 (2002) 666-668
20. Perry P., and Evans H.J. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature 258 (1975) 121-125
21. Picerno P., Autore G., Marzocco S., Meloni M., Sanogo R., and Aquino R.P. Anti-inflammatory activity of verminoside from Kigelia africana and evaluation of cutaneous irritation in cell cultures and reconstituted human epidermis. J. Nat. Prod. 68 (2005) 1610-1614
22. Pu X., Somg Z., Li Y., Tu P., and Li H. Acteoside from Cistanche salsa inhibits apoptosis by 1-methyl-4-phenylpyridimium ion in cerebellar granule neurons. Planta Med. 69 (2003) 65-66
23. Rigano D., Formisano C., Basile A., Lavatola A., Senatore F., Rosselli S., and Bruno M. Antibacterial activity of flavonoids and phenylpropanoids from Marrubium globosum ssp. libanoticum. Phytother. Res. 21 (2006) 395-397
24. Sarnataro D., Pisanti S., Santoro A., Gazzerro P., Malfitano A.M., Laezza C., and Bifulco M. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. Mol. Pharmacol. 70 (2006) 1298-1306
25. Süsse S., Scholz C.J., Burkle A., and Wiesmuller L. Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells. Nucleic Acids Res. 32 (2004) 669-680
26. Valenzuela M.T., Guerrero R., Nunez M.I., Ruiz De Almodovar J.M., Sarker M., de Murcia G., and Oliver F.J. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene 21 (2002) 1108-1116
27. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., and Bechimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose)polymerase. EMBO J. 16 (1997) 6018-6033
28. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
29. Wang Z.Q., Stingl L., Morrison C., Jantsch M., Los M., Osthoff K.S., and Wagner E.F. Genes Dev. 11 (1997) 2347-2358
30. Whitacre C.M., Hashimoto H., Tsai M.L., Chatterjee S., Berger S.J., and Berger N.A. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 55 (1995) 3697-3701
31. Wong I.Y., He Z.D., Huang Y., and Chen Z.Y. Antioxidative activities of phenylethanoid glycosides from Ligustrum purpurascens. J. Agric. Food Chem. 49 (2001) 3113-3119
32. Xiong Q., Kadota S., Tani T., and Namba T. Antioxidative effects of phenylethanoids from Cistanche deserticola. Biol. Pharm. Bull. 19 (1996) 1580-1585
33. Xiong Q., Tezuka Y., Kaneko T., Li H., Tran L.Q., Hase K., Namba T., and Kadota S. Inhibition of nitric oxide by phenylethanoids in activated macrophages. Eur. J. Pharmacol. 400 (2000) 137-144